Last reviewed · How we verify
NCT05581940: CEB
Pediatric Caudal Anesthesia Block. And Pain Control
trial testing Group A Caudal Epidural Anesthesia with bupivacaine 0.25% and group B with opioid intervenors in Pain, Postoperative in 72 participants. Completed in 19 July 2022.
10 July 2020
Quick facts
| Lead sponsor | Salmaniya Medical Complex |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 72 |
| Start date | 5 January 2020 |
| Primary completion | 10 July 2020 |
| Estimated completion | 19 July 2022 |
| Sites | 1 location across Bahrain |
Drugs / interventions tested
- Group A Caudal Epidural Anesthesia with bupivacaine 0.25% and group B with opioid intervenors
Conditions studied
- Pain, Postoperative — all drugs for Pain, Postoperative →
- Adverse Reaction to Epidural Anesthesia — all drugs for Adverse Reaction to Epidural Anesthesia →
- Anesthesia, Caudal — all drugs for Anesthesia, Caudal →
Sponsor
Salmaniya Medical Complex — full company profile →
Who can join
Adults 3 Months to 6, any sex, with Pain, Postoperative or Adverse Reaction to Epidural Anesthesia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Caudal epidural block CEB is the most commonly performed neuraxial block to provide effective pain relief and analgesia in patients undergoing infra-umbilical pediatric surgery. This study aimed to compare the effectiveness of adding CEB to general anesthesia in terms of intra- and post-operative pain management. Design: Double-unblinded. Prospective. randomized. Study, Setting: salmanyia medical complex. intraoperative, postoperative recovery room Methods: A total of 72 patients American Society of Anesthesiology physical status classification ASA 1. Patients were equally allocated into two groups Group A and with CEB and Group B without CEB, aged two months to six years. respectively, over a study period of six months. Both groups were compared based on hemodynamic stability, level of sedation, analgesia need, pain score, and parental satisfaction. Postoperative pain was evaluated by four different pain scales.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05581940
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pain, Postoperative
Currently open trials in the same condition.
- NCT07512141 — Single Versus Double Drains in the Axillary and Pectoral Regions After Modified Radical Mastectomy · NA · recruiting
- NCT07354581 — Erector Spinae Plane Block vs Quadro-Iliac Plane Block After Lumbar Instrumentation Surgery · NA · recruiting
- NCT07239817 — PENG Block + LIA For Endoprosthesis Surgery With Anterior Approach · NA · recruiting
- NCT06740214 — Analgesic Efficacy of Different Liposomal Bupivacaine Doses in the Adductor Canal Block for Total Knee Arthroplasty · Phase 3 · recruiting
- NCT07057557 — Aloe Vera vs Paraffin Tulle Dressings for Pain Management in Split Thickness Skin Graft Donor Sites · NA · recruiting
Other Salmaniya Medical Complex trials
Trials by the same sponsor.
- NCT06086106 — Comparison Between the Caudal Block and Other Methods of Postoperative Pain Relief in Children Undergoing Circumcision · completed
- NCT05012319 — Phase 3 Clinical Study Evaluating Nitric Oxide Nasal Spray (NONS) Efficacy To Treat and Prevent the Exacerbation of Infe · Phase 3 · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05581940 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Salmaniya Medical Complex
- Last refreshed: 17 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05581940.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing